Insmed (INSM) Net Margin Growth (1y) (2011 - 2026)
Insmed (INSM) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 447.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 673.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,097.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,208.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,636.00 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29,636.00 |
| Mar 31, 2026 | 22,296.00 |
| Dec 31, 2025 | 10,103.00 |
| Sep 30, 2025 | -2,391.00 |
| Jun 30, 2025 | 3,327.00 |
| Mar 31, 2025 | -6,835.00 |
| Dec 31, 2024 | -322.00 |
| Sep 30, 2024 | -3,505.00 |
| Jun 30, 2024 | -1,576.00 |
| Mar 31, 2024 | 3,692.00 |
| Dec 31, 2023 | 4,771.00 |
| Sep 30, 2023 | -737.00 |
| Jun 30, 2023 | -17,034.00 |
| Mar 31, 2023 | -6,681.00 |
| Dec 31, 2022 | -6,872.00 |
| Sep 30, 2022 | 4,743.00 |
| Jun 30, 2022 | 11,196.00 |
| Mar 31, 2022 | 4,971.00 |
| Dec 31, 2021 | 4,550.00 |
| Sep 30, 2021 | -9,520.00 |